Data Characteristics in Target Discovery
Target discovery data primarily originates from research papers, patent literature, clinical trial reports, internal experimental records, and various bioinformatics databases. These documents update frequently, with new research and data continuously published. Document structures are complex, containing unstructured text (e.g., introductions, methods, discussions), semi-structured tables (e.g., compound activity data, gene expression profiles), and structured data (e.g., compound SMILES strings, gene IDs, protein sequences). Fields and units are highly specific. Examples include compound IC50 values (typically nanomolar or micromolar), gene Entrez IDs, protein UniProt accession numbers, pathway names, disease ontologies (e.g., MeSH or ICD codes), and various experimental conditions.
Constraints on "Database and Operations" from These Characteristics
The data characteristics of target discovery documents impose unique requirements on databases and operations. First, diverse and frequently updated data sources necessitate efficient data ingestion and incremental update capabilities for the knowledge base to ensure timely information. Second, complex document structures and specialized fields require multi-modal data storage support. This includes vector databases for text embeddings, relational databases for structured metadata, and document databases for raw unstructured content. Highly specific fields and units demand rigorous entity recognition and unit conversion during data cleaning and standardization to ensure data accuracy and comparability. Furthermore, extensive biomolecular data and experimental parameters often require complex correlation and aggregation queries. This mandates robust query optimization capabilities and sufficient computational resources from the database. The system also needs elastic scalability to maintain service stability when facing potentially high concurrent parsing requests.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
UPLOAD_FILE_MAX_SIZE | 500 MB | Target discovery documents (e.g., patents, reviews) can contain numerous charts and detailed descriptions, leading to large individual files. |
maxContext | 3000 | Biomedical concepts are dense, requiring a larger context window to capture complex relationships. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Parsing large files and extracting complex structured information takes longer; this prevents parsing interruptions. |
Chunk size | 800 characters | Ensures each text segment contains sufficient biological context for effective vector embedding. |
Recall count | Top 10 entries | Increases the recall rate of relevant information, covering more potential target-related entities or pathways. |
Similarity threshold | 0.75 | For specialized terminology and concepts, a higher threshold filters for more precise matching results. |
Three Common Pitfalls
- Timeout errors during large file parsing often occur because the
PARSE_FILE_TIMEOUT_SECONDSparameter is set too low. It fails to account for the complexity and size of biomedical documents. - User queries for target information may return insufficient relevance. This can happen if the
Chunk size(segment length) is set too short, truncating critical context and impacting vector embedding quality. - After FastGPT installation and startup, if the expected
mongo/datadirectory is not created or is empty, it usually indicates the MongoDB container did not start correctly or data volume mapping is misconfigured, preventing data persistence.
How to Verify Configuration
- Upload and parse a typical large PDF document from the target discovery domain (e.g., a 50 MB review paper). Check if the parsing status is successful and the time taken is within expectations.
- Through the FastGPT management interface, view the knowledge base segment preview of the parsed document. Confirm that key entities, such as gene names and compound structures, are identified, and relevant context is complete.
- Execute a series of queries containing specialized terms and entity names, such as "PD-1 inhibitor mechanism of action" or "KRAS G12C mutation." Check the accuracy and richness of the returned results. Evaluate if their recall and precision meet business requirements.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.